Combo Treatment Could Delay Kidney Failure for Years in Nondiabetic CKD

Big benefits projected with SGLT2/RAAS inhibitor combination therapy

Related Keywords

China ,Guangzhou ,Guangdong ,New York ,United States ,Netherlands ,Groningen ,American ,Amy Mottl ,Evan Zeitler ,University Of North Carolina At Chapel Hill ,University Medical Center Groningen ,Priya Vart ,Clinical Journal ,American Society ,Improving Global Outcome ,North Carolina ,Chapel Hill ,Ramipril Efficacy ,Adverse Outcomes ,Chronic Kidney Disease ,New York City ,